With AKLIEF® (trifarotene) Cream, 0.005%

Make clearer skin a possibility for your patients.

A closer look: RESULTS THEY CAN SEE.

Study 18251: Double-blind, randomized, vehicle-controlled safety and efficacy 12-week trial of trifarotene cream vs vehicle cream.
Subject: 8511-004 | Age: 16 | Gender: Female

Study 118295: Open label, single arm study of trifarotene cream for 24 weeks.
Subject: 8447-004 | Age: 16 | Gender: Male

Study 18251: Double blind, randomized, vehicle-controlled safety and efficacy 12 week trial of trifarotene cream vs vehicle cream.
Subject: 8511-004 | Age: 16 | Gender: Female

Study 118295: Open label, single arm study of trifarotene cream for 24 weeks.
Subject: 8240-010 | Age: 14 | Gender: Male

Image

Treating acne doesn't have to break the bank.*

PATIENT SAVINGS CARD
Image

HELP THEM ACHIEVE
TREATMENT SUCCESS.

PATIENT RESOURCES

*Galderma CareConnect is only available for commercially-insured or uninsured patients. Patients who are enrolled in a government-run or government-sponsored healthcare plan with a pharmacy benefit are not eligible to use the Galderma CareConnect Patient Savings Card.

IMPORTANT SAFETY INFORMATION

Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Warnings/Precautions: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Please see full Important Safety Information below.

Scroll to ISI